Multiple Sclerosis
From the Journals
Neurologic disorders ubiquitous and rising in the U.S.
Most of the rise in disease burden could be attributed to population aging, while age-standardized figures showed stroke and dementias to be level...
Literature Review
MS bears no effect on certain pregnancy complications, stillbirth, or congenital deformation
Women with MS were more likely to have elective C-sections, induced labor, and babies with low birth weight based on their gestational age.
News
FDA approves intramuscular administration for peginterferon beta-1a in MS
The approval is based on data evaluating bioequivalence and adverse reactions associated with intramuscular administration compared with...
Literature Review
Is the EDSS an adequate outcome measure in secondary progressive MS trials?
Investigators say it may be time to replace as a primary outcome measure an instrument that registers more improvement than is likely possible in...
Literature Review
Stem cell transplant shows long-term benefit in MS
“Autologous hematopoietic stem cell transplant should be considered as a treatment strategy for MS not responding to conventional therapy.”
News
Physicians react: Doctors worry about patients reading their clinical notes
As part of the 21st Century Cures Act, patients will now have the right to see their medical notes.
Literature Review
Which imaging criteria identify progressive forms of MS?
Identification of imaging features associated with primary progressive MS and features that predict evolution from relapsing-remitting MS to...
Guidelines
Joint guidelines favor antibody testing for certain Lyme disease manifestations
The Infectious Disease Society of America, American Academy of Neurology, and the American College of Rheumatology teamed up for the first time to...
Supplements
Best of 2020: The MS Report
Hitting a Nerve
Do general neurologists fall victim to a plethora of treatment options?
Are a widening array of treatment options pushing MS into the realm of subspecialist care?
Conference Coverage
NfL blood biomarker captures suboptimal treatment response in MS
“Our data in this well-characterized large real-world cohort supports the value of serum NfL levels for treatment monitoring in MS clinical...